
A great post by @glyn_dk on evaluating strategies in drug discovery programs.enlightenbio.com/news-and-featu…
The market is big, but without efficiency, it hasn't made sense. $ETX brings that efficiency.
curationconnect.com/etherapeutics
English
Biotech - Curation
13 posts

@BiotechCuration
Insights on AI & drug discovery, genetics, computational biology & the future of medicine! Not investment advice, disclaimers on our website.






Pharmaceutical companies last year launched new U.S. drugs at prices 35% higher than in 2022, reflecting in part the industry's embrace of expensive therapies for rare diseases like muscular dystrophy, a Reuters analysis found. reut.rs/4c1iV71 reut.rs/4c1iV71






$SLN Announces Oversubscribed $120M Private Placement. 5.71M ADS at $21/ADS. Investors include Logos Capital, 5AM Ventures, Frazier Life Sciences, Nextech Invest, Redmile Group, TCGX and Vivo Capital.



